The goal is quantitative cerebral blood flow

Journal of Neuroradiology

Volumn 32, Issue 5, 2005, Pages 291-293

  Yonas, H ^a   Sesay, M ^a   Calli, C ^a   Liu, H M ^a   Lomena, F ^a   Nasel, C ^a   Meyer, J S ^a   Yunten, N ^a   Anckarsater, H ^a   Wintermark, M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

XENON 133;

BRAIN BLOOD FLOW; BRAIN REGION; DOPPLER ECHOGRAPHY; EDITORIAL; INTRACRANIAL PRESSURE MONITORING; NEUROIMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 29944442336     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0150-9861(05)83158-X     Document Type: Editorial

References (35)

1. AGNOLI A, PRENCIPE M, PRIORI AM, BOZZAO L, FIESCHI C. Measurements of rCBF by intravenous injection of Xe133: A comparitive Study with the intra-arterial injection method. In: Brock M, Frieschi C, Ingvar DH, Lassen NA, Schurmann K, eds. Cerebral Blood Flow. Berlin: Spinger-Verlag, 1969, pp 31-34.
2. ASTRUP J, SYMON L, SIESJO BK. Thresholds in cerebral Ischemia: The ischemic penumbra. Stroke 1981; 12: 723-725.
3. SYMON L, BRANSTON NM, STRONG AJ, HOPE TD. The concepts of thresholds of Ischemia in relation to brain structure and function. J Clin Pathol 1977; 30: 149-154 (suppl).
4. BARON JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001; 11 Suppl 1: 2-8.
5. CHIEREGATO A. Personal Communication.
6. CLYDE BL, RESNICK DK, YONAS H, SMITH HA, KAUFMANN AM. The relationship of blood velocity as measured by transcranial Doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage. Neurosurgery 1996; 38: 896-905.
7. DEWITT DS, FATOUROS PP, WIST AO, STEWART LM, KONTOS HA, HALL JA et al. Stable xenon versus radiolabeled microsphere cerebral blood flow measurements in baboons. Stroke 1989; 20: 1716-1723.
8. FATOUROS PP, WIST AO, KISHORE PR, DEWITT DS, HALL JA, KEENAN RL et al. Xenon/computed tomography cerebral blood flow measurements: methods and accuracy. Invest Radiol 1987; 22: 705-712.
9. GUR D, YONAS H, JACKSON DL, WOLFSON SK, ROCKETTE H, GOOD WF et al. Simultaneous measurements of cerebral blood flow by the xenon/CT method and the microsphere method: a comparison. Invest Radiol 1985; 20: 672-677.
10. GUR D, YONAS H, JACKSON DL, WOLFSON SK, ROCKETTE H, GOOD WF et al. Measurements of cerebral blood flow during xenon inhalation as measured by the microspheres method. Stroke 1985; 16: 871-874.
11. HAKIM AM. The cerebral ischemic penumbra. Can J Neurol Sci 1987; 14: 557-559.
12. HEISS WD, FORSTING M, DIENER HC. Imaging in Cerebrovascular Disease. Curr Opin Neurol 2001; 14: 67-75.
13. HOEDT-RAMUSSEN K, SVEINSDOTTIR E, LASSEN NA. Regional cerebral blood flow in man determined by intra-arterial injection of radioactive inert gas. Circ Res 1966; 18: 237-247.
14. HOSSMANN KA. Neuronal survival and revival during and after cerebral ischemia. Am J Emerg Med 1994; 1: 191-197.
15. HOSSMANN KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-565.
16. HOSHI H, OHNISHI T, JINNOUCHI S, FUTAMI S, NAGANACHI S, KODAMA T et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med 1994; 35: 44-50.
17. KURODA S, HOUKIN K, KAMIYAMA H, MITSUMORI K, IWASAKI Y, ABE H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001; 32: 2110-2116.
18. KUWABARA Y, ICHIYA Y, SASAKI M, AKASHI Y, YOSHIDA T, FUKUMURA T et al. Pre- and postoperative evaluation of perfusion reserve by acetazolamide 99mTc-HMPAO SPECT in patients with chronic occlusive cerebral arteries: A comparative study with PET. Kaku Igaku 1994; 31: 1039-1050.
19. MALLETT BL, VEALL N. The measurement of regional cerebral clearance rates in man using xenon133 inhalation and extracranial recording. Clin Sci 1965; 29: 179-191.
20. MATSUDA H, HIGASHI S, KINUYA K, TSUJI S, NOZAKI J, SUMIYA H et al. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO. Clin Nucl Med 1991; 16: 572-579.
21. MOODY EB, DAWSON RC III, SANDLER MP. 99mTc-HMPAO SPECT imaging in interventional neuroradiology: Validation of balloon test occlusion. AJNR Am J Neuroradiol 1991; 12: 1043-1044.
22. OBRIST WD, WILKINSON WE. Regional cerebral blood flow measurement in humans by Xenon-133 clearance. Cerebrovasc Brain Metab Rev 1992; 2: 283-327.
23. OBRIST WD, ZHANG Z, YONAS H. Effect of xenon-induced flow activation on xenon-enhanced computed tomography cerebral blood flow calculations. J Cereb Blood Flow Metab 1998; 18: 1192-5.
24. OGASAWARA K, OGAWA A, TERASAKI K, SHIMIZU H, TOMINAGA T, YOSHIMOTO T. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002; 22: 1142-1148.
25. OGASAWARA K, OGAWA A, YOSHIMOTO T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002; 33: 1857-1862.
26. PETERMAN SB, TAYLOR A JR, HOFFMAN JC. Improved detection of cerebral hypoperfusion with internal carotid balloon test occlusion and 99mTc-HMPAO cerebral perfusion SPECT imaging. AJNR Am J Neuroradiol 1991; 12: 1035-1041.
27. RYU YH, CHUNG TS, LEE JD, KIM DI, SUH JH, PARK CY et al. HMPAO SPECT to assess neurologic deficits during balloon test occlusion. J Nucl Med 1996;37:551-554.
28. SHVERA IY, CHERNIAVSKY AM, Ussov WY, PLOTNIKOV MP, SOKOLOV AA, SHIPULIN VM et al. Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery. Eur J Nucl Med 1995; 22: 132-138.
29. SYMON L, BRANSTON NM, STRONG AJ, HOPE TD. The concepts of thresholds of Ischemia in relation to brain structure and function. J Clin Pathol 1977; 30: 149-154.
30. WEBSTER MW, MAKAROUN MS, STEED DL, SMITH HA, JOHNSON DW, YONAS H. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995; 21: 338-345.
31. WITT JP, YONAS H, JUNGREIS C. Cerebral blood flow response pattern during balloon test occlusion of the internal carotid artery. AJNR Am J Neuroradiol 1994; 15: 847-856.
32. 14C] Iodoantipyrine for normal and low cerebral blood flow states in baboons. Stroke 1990; 21: 751-757.
33. YOKOTA C, HASEGAWA Y, MINEMATSU K, YAMAGUCHI T. Effect of acetazolamide reactivity on [corrected] long-term outcome in patients with major cerebral artery occlusive diseases. Stroke 1998; 29: 640-644.
34. YONAS H, PINDZOLA RR, MELTZER CC, SASSER H. Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 1998; 42: 1005-1012.
35. YONAS H, SMITH HA, DURHAM SR, PENTHENY SL, JOHNSON DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993; 79: 483-489.